Your browser doesn't support javascript.
loading
Cystic fibrosis: Does it matter to avoid crushing Elexacaftor/Tezacaftor/Ivacaftor (ETI) tablets?
Lebecque, Patrick; Thimmesch, Matthieu; Meurrens, Jessica; Jeanmart, Philippe.
Affiliation
  • Lebecque P; Cystic Fibrosis Reference Center of Liège, CHC MontLegia, Liège, Belgium.
  • Thimmesch M; Cystic Fibrosis Reference Center of Liège, CHC MontLegia, Liège, Belgium.
  • Meurrens J; Cystic Fibrosis Reference Center of Liège, CHC MontLegia, Liège, Belgium.
  • Jeanmart P; Clinical Chemistry Department, CHC MontLegia, Liège, Belgium.
Pediatr Pulmonol ; 58(12): 3603-3604, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37701935
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis Limits: Humans Language: En Journal: Pediatr Pulmonol Journal subject: PEDIATRIA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis Limits: Humans Language: En Journal: Pediatr Pulmonol Journal subject: PEDIATRIA Year: 2023 Document type: Article Affiliation country: Country of publication: